Transition Therapeutics Company Profile (NASDAQ:TTHI)

About Transition Therapeutics

Transition Therapeutics logoTransition Therapeutics Inc. is a product-focused biopharmaceutical company. The Company's principal business activity is the researching and developing of therapeutic agents. The Company is developing therapeutics for central nervous system (CNS) and metabolic disease indications. The Company's technologies are focused on the treatment of agitation and aggression in Alzheimer's disease and diabetes. The Company's subsidiary, Transition Therapeutics Ireland Limited (Transition Ireland), is developing two drug candidates: neuropsychiatric candidate ELND005 and androgen deficiency candidate TT701. The Company's subsidiary, Waratah Pharmaceuticals Inc. (Waratah), is developing diabetes drug candidate TT401. The Company's other two entities provide development services in support of the clinical and non-clinical activities of Transition Ireland and Waratah.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TTHI
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $1.59
  • 200 Day Moving Average: $1.11
  • 52-Week Range: $0.66 - $2.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.67
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 1.59
Additional Links:
Companies Related to Transition Therapeutics:

Analyst Ratings

Consensus Ratings for Transition Therapeutics (NASDAQ:TTHI) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Transition Therapeutics (NASDAQ:TTHI)
Show:
DateFirmActionRatingPrice TargetDetails
5/14/2016Cowen and CompanyReiterated RatingHoldView Rating Details
4/19/2016Canaccord GenuityReiterated RatingHoldView Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Transition Therapeutics (NASDAQ:TTHI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/15/2015Q415($0.39)($0.31)ViewN/AView Earnings Details
5/12/2015Q315($0.20)($0.11)ViewN/AView Earnings Details
2/10/2015($0.24)($0.38)ViewN/AView Earnings Details
11/12/2014Q312($0.18)($0.45)ViewN/AView Earnings Details
9/26/2014($0.28)($0.39)ViewN/AView Earnings Details
5/14/2014($0.07)($0.16)ViewN/AView Earnings Details
11/12/2013($0.11)($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Transition Therapeutics (NASDAQ:TTHI)
Current Year EPS Consensus Estimate: $-0.33 EPS
Next Year EPS Consensus Estimate: $-0.57 EPS

Dividends

Dividend History for Transition Therapeutics (NASDAQ:TTHI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Transition Therapeutics (NASDAQ:TTHI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Transition Therapeutics (NASDAQ:TTHI)
DateHeadline
finance.yahoo.com logoTransition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval … (NASDAQ:TTHI)
finance.yahoo.com - August 26 at 7:33 PM
streetinsider.com logoOPKO Health (OPK) Announces Transition Therapeutics (TTHI) Shareholder Approval of Proposed Acquisition (NASDAQ:TTHI)
www.streetinsider.com - August 26 at 10:49 AM
finance.yahoo.com logo8:53 am Transition Therapeutics shareholders approve merger with OPKO health (OPK (NASDAQ:TTHI)
finance.yahoo.com - August 26 at 10:49 AM
finance.yahoo.com logoTransition (TTHI) Stock Up on News of Acquisition by Opko (NASDAQ:TTHI)
finance.yahoo.com - July 1 at 8:59 AM
insidermonkey.com logoHere’s Why Traders Are Watching These Five Stocks Today (NASDAQ:TTHI)
www.insidermonkey.com - June 30 at 10:40 AM
News IconPhil Kessel scores twice as Pittsburgh Penguins eliminate Washington Capitals with 4-3 victory in OT (NASDAQ:TTHI)
www.theprovince.com - May 12 at 9:19 AM
sg.finance.yahoo.com logoTransition Therapeutics posts 3Q loss (NASDAQ:TTHI)
sg.finance.yahoo.com - May 11 at 4:23 PM
finance.yahoo.com logoTransition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results (NASDAQ:TTHI)
finance.yahoo.com - May 11 at 4:01 PM
finance.yahoo.com logoTransition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST (NASDAQ:TTHI)
finance.yahoo.com - May 9 at 4:01 PM
News IconTransition Therapeutics Ord (NASDAQ:TTHI) Shorted Shares Decreased By 8.42% - B.O.D.Y Confidential (NASDAQ:TTHI)
www.bodyconfidential.com - April 29 at 9:32 AM
streetinsider.com logoTransition Therapeutics (TTHI) Commences Dosing in TT701 Phase 2 in Androgen Deficiency - StreetInsider.com (NASDAQ:TTHI)
www.streetinsider.com - April 26 at 9:48 AM
finance.yahoo.com logoTransition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701 (NASDAQ:TTHI)
finance.yahoo.com - April 25 at 4:01 PM
wallstrt24.com logoAstraZeneca plc (NYSE:AZN) & Transition Therapeutics (NASDAQ:TTHI) Hot Stock's Alert - Wall Street 24 (NASDAQ:TTHI)
wallstrt24.com - April 19 at 10:17 AM
News IconActive Stocks Need to Consider- M&T Bank (NYSE:MTB), Transition Therapeutics. (NASDAQ:TTHI), GlaxoSmithKline ... - Seneca Globe (NASDAQ:TTHI)
www.senecaglobe.com - April 19 at 10:17 AM
nasdaq.com logoTransition: Lilly Not To Advance Diabetes Drug Candidate TT401 To Phase 3 (NASDAQ:TTHI)
www.nasdaq.com - April 18 at 9:57 AM
streetinsider.com logoTransition Therapeutics (TTHI) Says Lilly (LLY) Won't Advance TT401 into Phase 3 (NASDAQ:TTHI)
www.streetinsider.com - April 18 at 9:57 AM
investors.com logoTransition Therapeutics Inc to advance diabetes drug without Eli Lilly (NASDAQ:TTHI)
www.proactiveinvestors.com - April 18 at 9:57 AM
thestreet.com logoTransition Therapeutics Provides Update On Type 2 Diabetes Drug Candidate TT401 (NASDAQ:TTHI)
www.thestreet.com - April 18 at 6:34 AM
News IconMaking Impressive Motion: Transition Therapeutics Inc. (NASDAQ:TTHI), Sumitomo Mitsui Financial Group (NYSE ... - Property Mentor (NASDAQ:TTHI)
www.propertymentorgroup.com - April 14 at 2:14 PM
News IconTransition Therapeutics Ord (NASDAQ:TTHI) Short Interest Decreased By 5.4% - Stock Caller (NASDAQ:TTHI)
www.stockcaller.com - April 5 at 2:22 PM
finance.yahoo.com logoTransition Therapeutics Receives Notification From NASDAQ (NASDAQ:TTHI)
finance.yahoo.com - March 17 at 5:01 PM
finance.yahoo.com logoTransition Therapeutics to Present at the 36th Annual Cowen Healthcare Conference (NASDAQ:TTHI)
finance.yahoo.com - March 1 at 4:30 PM
News IconDETROIT — The moon turned blue on Tuesday and a pig was spotted flying near the Ottawa airport (NASDAQ:TTHI)
www.ad-hoc-news.de - February 10 at 12:33 PM
sg.finance.yahoo.com logoTransition Therapeutics posts 2Q loss (NASDAQ:TTHI)
sg.finance.yahoo.com - February 9 at 6:29 PM
finance.yahoo.com logoTransition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results (NASDAQ:TTHI)
finance.yahoo.com - February 9 at 4:30 PM
finance.yahoo.com logoTransition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST (NASDAQ:TTHI)
finance.yahoo.com - February 5 at 1:01 PM
finance.yahoo.com logoTransition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401 (NASDAQ:TTHI)
finance.yahoo.com - February 1 at 6:01 AM
finance.yahoo.com logoTransition Therapeutics Announces Annual General Meeting Voting Results (NASDAQ:TTHI)
finance.yahoo.com - January 6 at 6:01 AM
finance.yahoo.com logoTRANSITION THERAPEUTICS INC. Financials (NASDAQ:TTHI)
finance.yahoo.com - December 8 at 1:15 PM
finance.yahoo.com logoTransition Therapeutics to Host Investor Day November 23 in New York (NASDAQ:TTHI)
finance.yahoo.com - November 19 at 11:45 AM
sg.finance.yahoo.com logoTransition Therapeutics posts 1Q loss (NASDAQ:TTHI)
sg.finance.yahoo.com - November 10 at 4:21 PM
finance.yahoo.com logoTransition Therapeutics Announces First Quarter Fiscal 2016 Financial Results (NASDAQ:TTHI)
finance.yahoo.com - November 10 at 4:01 PM
noodls.com logoAppointment of Non-Executive Director (G Pace) (NASDAQ:TTHI)
www.noodls.com - November 8 at 8:26 PM
finance.yahoo.com logoTransition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST (NASDAQ:TTHI)
finance.yahoo.com - November 2 at 6:01 AM
finance.yahoo.com logoTransition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug Candidate (NASDAQ:TTHI)
finance.yahoo.com - October 29 at 4:01 PM

Social

What is Transition Therapeutics' stock symbol?

Transition Therapeutics trades on the NASDAQ under the ticker symbol "TTHI."

How do I buy Transition Therapeutics stock?

Shares of Transition Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Transition Therapeutics stock cost?

One share of Transition Therapeutics stock can currently be purchased for approximately $1.52.

Transition Therapeutics (NASDAQ:TTHI) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Transition Therapeutics (NASDAQ:TTHI)

Earnings History Chart

Earnings by Quarter for Transition Therapeutics (NASDAQ:TTHI)

Dividend History Chart

Dividend Payments by Quarter for Transition Therapeutics (NASDAQ:TTHI)

Last Updated on 2/22/2017 by MarketBeat.com Staff